← All candidates
One insider buy in the last year — $4.6K in all.
29 filings on record.
SPRBSPRUCE BIOSCIENCES, INC.
NasdaqCM · Healthcare · $154.33M
$53.70
-1.20% · Sep 11
One insider buy in the last year — $4.6K in all.
Nothing in the last fortnight.
Price · 1Y · daily● 1 buy● 2 sells◆ 5 8-K
▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges · 4 moves explained
Reverse-split 2×. When a company does a reverse split, the chart rewrites its old prices to look far bigger than they really were — so the high early prices here aren't what SPRB ever actually traded at. The drop is real, but those huge old numbers aren't.
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$154.33M
Float
2.0M
70% public
Short % float
Pro
Price / profit
—
not yet profitable
Price / future profit
6.6
Price / sales
—
The buyers
▸ each insider's past open-market buys, measured ~6 months (120 trading days) later, against the S&P over the same spans · split-adjusted · pre-scheduled 10b5-1 plan trades excluded · past outcomes, not predictions
10% owner
Parkman Healthcare Partners LLC
Bought $4.6K on Oct 6 — 256 sh @ $17.91, held indirect, 20% of their stake.
0 of 1 position beat the S&P
Institutional stakes
▸ a holder crossing 5% files Schedule 13D if they intend to act on the company, 13G if they certify they will not · /A amends an earlier filing
4 filingsnewest first
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
20 more transactions on Pro →The file stays open
29 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice